Prytime Medical Devices, Inc.

Prytime Medical Devices, Inc. is an innovative medical device company specializing in minimally invasive solutions for hemorrhage control. The company designs, develops, and commercializes REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) technology—a minimally invasive technique using balloon catheters to temporarily occlude large vessels in support of hemorrhage control. REBOA addresses non-compressible truncal hemorrhage, the leading cause of potentially survivable death in trauma. The company's primary product is the ER-REBOA™ PLUS Catheter, a clinical-grade device designed for emergency resuscitation. Additionally, Prytime Medical is developing the pREBOA-PRO™, described as a true partial REBOA system for enhanced hemorrhage control capabilities. Beyond trauma, clinicians report REBOA use in postpartum hemorrhage, surgical procedures, interventional radiology, and pre-hospital settings. The company maintains a US headquarters in Boerne, Texas, with sales and distribution through multiple international representatives across Europe and beyond. Contact is available via sales@prytimemedical.com and 210.340.0116. Prytime Medical positions itself as "The REBOA Company™" and emphasizes the clinical evidence supporting REBOA outcomes, including reported mortality risk reduction of 23% per year as practice evolves. The company provides patient education materials and clinical case studies demonstrating survival outcomes. All products are subject to FDA regulations and include comprehensive package inserts with indications, contraindications, precautions, and warnings.